Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mechanism of Pasireotide-Induced Hyperglycemia in Healthy Volunteers
NCT01128192Phase 2Completed
- Start
- Aug 2009
- Primary completion
- Apr 2010
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pasireotide LAR in Cushing's disease (CD), acromegaly. Started Aug 2009; status: completed.
02
Drugs
pasireotide LAR
03
Conditions
Cushing's disease (CD)acromegaly
Beyond the preview
Go deeper on NCT01128192.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01128192.